Clinical Trial

A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure

Name: A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure — clinical trial record (NCT07562087)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is designed to evaluate the safety, tolerability, and pharmacokinetics of TP05 administered orally to healthy adult participants.

Protocol Amendment History 1 change

critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-10

Trial Details

NCT Number	NCT07562087
Lead Sponsor	Tarsus Pharmaceuticals, Inc. Collaborators: PPD Development, LP
Conditions	Lyme Disease
Enrollment	722 participants
Start Date	2026-03-09
Primary Completion	2027-10 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-09